期刊文献+

LKB1对胰腺癌细胞迁移侵袭及上皮间质转化的影响及机制研究 被引量:4

Effects of LKB1 on Migration,Invasion and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma Cells
下载PDF
导出
摘要 目的研究LKB1基因对人胰腺癌细胞迁移侵袭及上皮间质转化的影响及机制。方法将LKB1过表达质粒转染至人胰腺癌细胞ASPC-1,实验分为转染试剂组、空载体组和LKB1过表达组。Western blot检测细胞转染后LKB1蛋白的表达水平;划痕实验和Transwell实验分别检测LKB1过表达对人胰腺癌细胞ASPC-1迁移、侵袭能力的影响;Western blot检测LKB1过表达对AMPKα、p-AMPKα及上皮间质转化相关蛋白E-钙黏蛋白(E-cadherin)、N-钙黏蛋白(N-cadherin)、波形蛋白(Vimentin)表达的影响。结果与转染试剂组相比,LKB1过表达质粒转染人胰腺癌细胞ASPC-1后LKB1蛋白表达水平明显增高(P<0.01),细胞迁移、侵袭能力均显著降低(P<0.01),p-AMPKα及上皮细胞标志物E-cadherin的蛋白相对表达水平增高(P<0.01),间质表型细胞标志物N-cadherin和Vimentin蛋白相对表达水平显著下降(P<0.01)。结论 LKB1抑制人胰腺癌细胞ASPC-1的迁移、侵袭和上皮间质转化,该抑制过程可能通过激活AMPK信号通路发挥作用。 Objective To investigate the effects and mechanism of LKB1 on migration, invasion and epithelial-mesenchyma] transition in human pancreatic carcinoma cells. Methods Human pancreatic carcinoma ASPC-1 cells were transfected with pcDNA3.1-LKB1. The experiment was divided into Mock, Vector and Vector-LKB1 group. The protein expression level of LKB1 was validated by Western blot. Cell migration and invasion ability was determined by the scratch tests and Transwell assay. The protein expression level of AMPKα, p-AMPKα and epithelial-mesenchymal transition(EMT)-related markers( E-cadherin, N-cadherin and Vimentin) were assayed by Western blot analysis. Results The protein expression level of LKB1 was significantly increased in Vector-LKB1 group compared with the Mock group(P 〈 0.01 ), and the ability of cell migration and invasion was strongly reduced( P 〈 0.01 ). Increased expression of p-AMPKα, epithelial marker(E-cadherin) and decreased expression of mesenchyma] markers( N-cadherin, Vimentin) were observed in Vector-LKB1 group compared with the Mock group( P 〈 0.01 ). Conclusion LKB1 inhibit migration, invasion ability and epithelial-mesenchymal transition of human pancreatic carcinoma ASPC-1 cells, which may act through activating AMPK signaling pathway.
机构地区 辽宁省人民医院
出处 《实用癌症杂志》 2016年第3期362-365,372,共5页 The Practical Journal of Cancer
关键词 LKB1 胰腺癌 迁移 侵袭 上皮间质转化 LKB 1 Pancreatic carcinoma Migration Invasion Epithelial-mesenchymal transition
  • 相关文献

参考文献17

  • 1Siegel tt, Naishadham D, Jemal A. Cancer statistics, 2012 [J].CA Cancer J Clin,2012,62( 1 ) :10-29.
  • 2Vincent A, Herman J, Schulick R, et al. Pancreatic cancer [J]. Lancet,2011,378(9791 ) :607-620.
  • 3李慧超,王宁,郑荣寿,张思维,陈万青.中国2010年胰腺癌发病和死亡分析[J].中国肿瘤,2015,24(3):163-169. 被引量:60
  • 4Bonnomel A, B~sse A ,Tachsidis A ,el al. I']pilhelial-to-me- senchymal transitions and circulating tumor cells[J].J Mamma~ Gland Biol Neoplasia ,2010,15 ( 2 ) :261-273.
  • 5Sahin F, Maitra A, Argani P, et al. Loss of Stkl l/1,kbl ex- pression in pancreatic and lfiliary neoplasms[J]. Mod Pathol, 2003,16 ( 7 ) :686-691.
  • 6Qanungo S, Haldar S, Basu A. Restoration o1" silenced Peulz- Jeghers syndrome gene, LKBI ,induces apoptosis in pant:te- a!it carcinoma cells[ J ]. Neoplasla ,2003,5 ( 4 ) :367-374.
  • 7Hidalgo M. Pancreatic cancer[ J]. N Engl J Med,2010,362 (17) :1605-1617.
  • 8De Wilde RF, Ottenhof NA, Jansen M, et al. Analysis of LKB1 mutations and other molecular alterations in pancre- atic acinar cell carcinoma [J].Mod Pathol, 2011,24 ( 9 ) : 1229-1236.
  • 9Morton JP,Jamieson NB, Karim SA, et al. LKB1 haploinsuf- ficiency cooperates with Kras to promote pancreatic cancer through suppression of io21-dependent growth arrest[J].Gastroenterology, 201 O, 139 ( 2 ) : 586 -597.
  • 10Gan RY, Li HB. Recent progress on liver kinase B1 ( LKB- 1 ) : expression, regulation, downstream signaling and cancer suppressive function[J]. Int J Mol Sci, 2014, 15 ( 9 ) : 16698-16718.

二级参考文献11

共引文献59

同被引文献50

  • 1沈赞,吴晴,岳麓,李鹤成,沈镇宙,邵志敏.抑癌基因LKB1在乳腺癌组织中的表达及其临床意义[J].中华医学杂志,2005,85(1):15-18. 被引量:7
  • 2庄志刚,狄根红,侯意枫,刘刚,罗建民,沈镇宙,邵志敏.LKB1基因与乳腺癌细胞侵袭性相关因子的研究[J].中华医学杂志,2007,87(2):81-84. 被引量:7
  • 3梁璇,南克俊,徐勤枝.丝氨酸/苏氨酸蛋白激酶1基因沉默对肺癌细胞生物学行为的影响[J].南方医科大学学报,2007,27(9):1303-1306. 被引量:3
  • 4Green AS, Chapuis N, Lacombe C, et al. LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology [ J ]. Cell Cycle, 2011,10 ( 13 ) : 2115-2120.
  • 5Feng Y, Wang Y, Wang Z, et al. The CRTC 1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss [ J ]. Cancer Res, 2012,72(24) :6502-6511.
  • 6Osoegawa A, Kometani T, Nosaki K, et al. LKB1 mutations fre-quently detected in mucinous bronchioloalveolar carcinoma [ J ] .Jpn J Clin Oncol, 2011, 41 (9) : 1132-1137.
  • 7Van Veelen W, Korsse SE, van de Laar L, et al. The long and winding road to rational treatment of cancer associated with LKB1, AMPK/TSC/mTORC1 signaling[ J3. Oncogene, 2011, 30 (20) : 2289 -2303.
  • 8Mehellou Y, Alessi DR, Macartney TJ, et al. Structural insights into the activation of MST3 by MO25 [ J]. Biochem Biophys Res Commun, 2013,431(3) : 604-609.
  • 9EkmanS, Wynes MW, Hirsch FR. The mTOR pathway in lung cancer and implications for therapy and biomarker analysis [ J ]. Thorac Oneol, 2012,7 (6) : 947-953.
  • 10Grewe M, Gansauge F, Schmid RM, et al. Regulation of cell growth and cyclin D1 expression by the constitutively active FPAP- p7Os6K pathway in human pancreatic cancer ceils [ J ]. Cancer Res, 1999,59(15) :3581-8587.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部